Kedaung Indah Can Tbk vs Merck Tbk. — how do they compare? Kedaung Indah Can Tbk trades at Rp187 (market cap 51.89B, 111.6K 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merck Tbk. is far larger — about 32.8× Kedaung Indah Can Tbk's market cap, and Kedaung Indah Can Tbk is more actively traded (111.6K versus 37.6K). Which is the better fit depends on your goals.
| KICI | MERK | |
|---|---|---|
Market Cap | 51.89B | 1.7T |
Volume | 111.6K | 37.6K |
Lot | 1.12K | 376 |
Turnover | 20.67M | 144.47M |
Average Price | 185.23 | 3,842.23 |
Value | 20.67M | 144.47M |
Indicative Equilibrium Price | — | 3,840 |
Indicative Equilibrium Volume | — | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Kedaung Indah Can Tbk (the Company) was established within the framework of the Domestic Capital Investment Law No. 6 year 1968 as amended by Law No. 12 year 1970, based on Notarial Deed No. 37, dated January 11, 1974 of Julian Nimrod Siregar Gelar Mangaradja Namora, S.H., notary in Jakarta. The Company produces Cans and Enamel kitchenware. The company`s products have been exported since 1988, mostly to US, Saudi Arabia, and Japan, an also to Europe and South America.
Read more on KICI →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →